Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Dec. 31, 2018 | Feb. 13, 2019 | |
Document Information [Line Items] | ||
Entity Registrant Name | Americann, Inc. | |
Entity Central Index Key | 1,508,348 | |
Trading Symbol | acan | |
Current Fiscal Year End Date | --09-30 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Current Reporting Status | Yes | |
Entity Emerging Growth Company | false | |
Entity Small Business | true | |
Entity Common Stock, Shares Outstanding (in shares) | 22,903,615 | |
Document Type | 10-Q | |
Document Period End Date | Dec. 31, 2018 | |
Document Fiscal Year Focus | 2,019 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false |
Consolidated Balance Sheets (Cu
Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Dec. 31, 2018 | Sep. 30, 2018 |
Current Assets: | ||
Cash and cash equivalents | $ 71,817 | $ 198,144 |
Restricted cash | 4,435,085 | 3,818,805 |
Current portion of prepaid land lease | 57,959 | 57,959 |
Prepaid expenses and other current assets | 7,320 | 7,470 |
Current portion of note receivable - related party | 24,683 | |
Total current assets | 4,596,864 | 4,082,378 |
Construction in progress | 1,708,115 | 1,681,382 |
Furniture and equipment (net of depreciation of $461 and $4,827) | 2,303 | 5,794 |
Notes and other receivables (net of allowance of $977,770) | 783,905 | 783,905 |
Note receivable - related party | 146,486 | 176,764 |
Prepaid land lease and related deposits, net of current portion | 2,709,598 | 2,724,088 |
Security deposit and other assets | 3,110 | 3,110 |
Total assets | 9,950,381 | 9,457,421 |
Current Liabilities: | ||
Accounts payable and accrued expenses | 59,627 | 268,065 |
Related party payables | ||
Interest payable (including $219 and $12,742 to related parties) | 44,491 | 46,605 |
Other payables | 5,025 | 8,906 |
Notes payable (net of discount of $0 and $138,750) | 615,000 | 521,250 |
Notes payable - related party (inclusive of premium of $20,332 and $0) | 1,776,978 | |
Total current liabilities | 2,501,121 | 844,826 |
Notes payable - related party (inclusive of premium of $0 and $25,673) | 1,782,319 | |
Total liabilities | 2,501,121 | 2,627,145 |
Commitments and contingencies - see Note 10 | ||
Stockholders' Equity: | ||
Preferred stock, $0.0001 par value; 20,000,000 shares authorized; no shares issued and outstanding | 0 | 0 |
Common stock, $0.0001 par value; 100,000,000 shares authorized; 22,782,907 and 21,106,706 shares issued and outstanding as of December 31, 2018 and September 30, 2018, respectively | 2,279 | 2,211 |
Additional paid in capital | 21,095,030 | 19,937,606 |
Accumulated deficit | (13,648,049) | (13,109,541) |
Total stockholders' equity | 7,449,260 | 6,830,276 |
Total liabilities and stockholders' equity | $ 9,950,381 | $ 9,457,421 |
Consolidated Balance Sheets (_2
Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($) | Dec. 31, 2018 | Sep. 30, 2018 |
Furniture and equipment, accmulated depreciation | $ 461 | $ 4,827 |
Notes and other receivables, allowance | 977,770 | 977,770 |
Interest payable, related parties | 219 | 12,742 |
Note payable, discount | 0 | 138,750 |
Note payable, related party, premium, current | 20,332 | 0 |
Notes payable, related party, premium, noncurrent | $ 0 | $ 25,673 |
Preferred stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares authorized (in shares) | 20,000,000 | 20,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Preferred stock, shares outstanding (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 |
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Common stock, shares issued (in shares) | 22,782,907 | 22,106,706 |
Common stock, shares outstanding (in shares) | 22,782,907 | 22,106,706 |
Consolidated Statements of Oper
Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Revenues: | ||
Revenues | ||
Operating expenses: | ||
Advertising and marketing | 16,856 | 962 |
Professional fees | 128,933 | 151,987 |
General and administrative expenses | 212,112 | 434,862 |
Total operating expenses | 357,901 | 587,811 |
Loss from operations | (357,901) | (587,811) |
Other income (expense): | ||
Interest income | 7,672 | 8,077 |
Interest expense | (151,388) | (754,379) |
Other income (expense) | (3,030) | (2,861) |
Interest expense - related party | (33,861) | (37,390) |
Total other income (expense) | (180,607) | (786,553) |
Net loss | $ (538,508) | $ (1,374,364) |
Basic and diluted loss per common share (in dollars per share) | $ (0.02) | $ (0.07) |
Weighted average common shares outstanding (in shares) | 22,568,375 | 19,366,000 |
Service [Member] | ||
Revenues: | ||
Revenues |
Consolidated Statements of Chan
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) | Preferred Stock [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Balances (in shares) at Sep. 30, 2017 | 19,366,000 | ||||
Balances at Sep. 30, 2017 | $ 1,937 | $ 10,959,188 | $ (8,676,825) | $ 2,284,300 | |
Stock-based compensation expense | 171,307 | 171,307 | |||
Benefical conversion feature and warrants | 1,487,438 | 1,487,438 | |||
Net loss | (1,374,364) | (1,374,364) | |||
Balances (in shares) at Dec. 31, 2017 | 19,366,000 | ||||
Balances at Dec. 31, 2017 | $ 1,937 | 12,617,933 | (10,051,189) | $ 2,568,681 | |
Balances (in shares) at Sep. 30, 2018 | 22,106,763 | 22,106,706 | |||
Balances at Sep. 30, 2018 | $ 2,211 | 19,937,606 | (13,109,541) | $ 6,830,276 | |
Net loss | (538,508) | (538,508) | |||
Stock issued for cash (in shares) | 311,816 | ||||
Conversion of debt (in shares) | 31,328 | ||||
Conversion of debt | $ 3 | 46,989 | $ 46,992 | ||
Stock issued for warrants exercised, net (in shares) | 308,000 | 308,000 | |||
Stock issued for warrants exercised, net | $ 31 | 395,469 | $ 395,500 | ||
Stock Issued During Period, Shares, Issued for Services | 25,000 | ||||
Stock issued for services | $ 3 | 64,997 | $ 65,000 | ||
Balances (in shares) at Dec. 31, 2018 | 22,782,907 | 22,782,907 | |||
Balances at Dec. 31, 2018 | $ 2,279 | 21,095,030 | (13,648,049) | $ 7,449,260 | |
Stock issued for cash | $ 31 | $ 649,969 | $ 650,000 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Cash flows from operating activities: | ||
Net loss | $ 538,508 | $ 1,374,364 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation and amortization | 461 | 3,739 |
Stock based compensation and option expense | 171,307 | |
Stock issued for services | 65,000 | |
Amortization of equity instruments issued to lessor | 9,865 | 14,490 |
Amortization of debt discount/(premium) | 133,409 | 708,645 |
Noncash interest income | (8,077) | |
Changes in operating assets and liabilities: | ||
Prepaid expenses | 150 | |
Accounts payable and accrued expenses | (203,813) | (178,215) |
Interest payable | (10,531) | 50,682 |
Interest payable - related party | 10,409 | (21,598) |
Other payables | (3,881) | 1,891 |
Net cash flows used in operations | (534,409) | (628,639) |
Cash flows from investing activities: | ||
Additions to construction in progress | (26,733) | (1,153) |
Payments received on notes receivable | 5,595 | |
Net cash flows used in investing activities | (21,138) | (1,153) |
Cash flows from financing activities: | ||
Common stock issued for cash, net | 650,000 | |
Proceeds from note payable, net of financing costs | 1,726,000 | |
Proceeds from the exercise of warrants | 395,500 | |
Net cash flows provided by financing activities | 1,045,500 | 1,726,000 |
Net increase in cash, cash equivalents, and restricted cash | 489,953 | 1,096,208 |
Cash, cash equivalents, and restricted cash at beginning of period | 4,016,949 | 1,627 |
Cash, cash equivalents, and restricted cash at end of period | 4,506,902 | 1,097,835 |
Supplementary Disclosure of Cash Flow Information: | ||
Cash paid for interest | 51,959 | 54,040 |
Cash paid for income taxes | 0 | 0 |
Proceeds from sale of land used to satisfy debt obligations | 1,608,451 | |
Debt discount related to warrants issued with debt and Beneficial Conversion Feature | 1,536,000 | |
Shares issued for converstion of debt and accrued interest | 46,992 | |
Land [Member] | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Loss on disposal of land | 2,861 | |
Fixed Asset [Member] | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Loss on disposal of land | $ 3,030 |
Note 1 - Nature of Business and
Note 1 - Nature of Business and Basis of Presentation | 3 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] | NOTE 1. AmeriCann, Inc. ("the Company", “we”, “our” or "the Issuer") was organized under the laws of the State of Delaware on June 25, 2010. On January 17, 2014, 93% The Company's business plan is to design, develop, lease and operate state-of-the-art cultivation, processing and manufacturing facilities for licensed cannabis businesses throughout the United States. The Company's activities are subject to significant risks and uncertainties including failure to secure funding to properly expand its operations. Certain prior period amounts have been reclassified to conform with current period presentation. These reclassifications have no Basis of Presentation The (a) balance sheet as of September 30, 2018, three December 31, 2018 2017, 10 January 15, 2019. not 2018 10 Certain prior period amounts have been reclassified to conform with current period presentation. These reclassifications have no Restricted Cash The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts in the consolidated statements of cash flows: December 31, September 30, 2018 Cash and cash equivalents $ 71,817 $ 198,144 Restricted cash 4,435,085 3,818,805 Total cash, cash equivalents, and restricted cash shown in the cash flow statement $ 4,506,902 $ 4,016,949 Amounts included in restricted cash represent those required to be set aside by a contractual agreement with a lender for the payment of specific construction related expenditures as part of the Company’s property development in Massachusetts. Recent Accounting Pronouncements In January 2018, No. 2018 01, 842 842; February 25, 2016, No. 2016 02, 842 842. 842 2016 02, not may 10 350 30. 1, 2019, 2016 02. 842 not In July 2017, No. 2017 11, 260 480 815 no December 15, 2018, October 1, 2018 not In May 2017, No. 2017 09, 718 1 2 718, 718. December 15, 2017, October 1, 2018 not In February 2017, No. 2017 05, 610 20 610 20, 610 20, May 2014 No. 2014 09, 606 December 15, 2017, No. 2014 09, 1, 2018 not In January 2017, No. 2017 03, 250 No. 2014 09, 606 No. 2016 02, 842 No. 2016 13, 326 No. 2014 09 1, 2018 not Between May 2014 December 2016, 606 five may December 15, 2017, 606, October 1, 2018 not In February 2016, No. 2016 02, 842 2016 02” 2016 02 2016 02, 12 2016 02 December 15, 2018 ( 2016 02 |
Note 2 - Going Concern
Note 2 - Going Concern | 3 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Substantial Doubt about Going Concern [Text Block] | NOTE 2. The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. The Company had an accumulated deficit of $13,648,049 $13,109,541 December 31, 2018 September 30, 2018, $538,508 three December 31, 2018. $1,761,675 $977,770 may not may not January 18, 2018, $1,045,000 18% April 18, 2015 March 15, 2018 $550,000. $1,595,000, no not not Management believes that the actions presently being taken to further implement its business plan and generate revenue provide the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its strategy to generate revenue and in its ability to raise additional funds, there can be no not |
Note 3 - Notes and Other Receiv
Note 3 - Notes and Other Receivables | 3 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Loans, Notes, Trade and Other Receivables Disclosure [Text Block] | NOTE 3. Notes and other receivables as of December 31, 2018 September 30, 2018, December 31, September 30, 2018 Notes and other receivables from WGP, a licensed medical marijuana cultivator; $673,294 note secured by real and personal property of the borrower, interest rate of 18.0%; accrued consulting and legal fees of $206,675, construction advances of $332,357 and accrued interest of $549,349. Net of reserves of $977,770. All amounts are due and payable immediately. $ 783,905 $ 783,905 Related party note receivable from BASK, a non-profit corporation, interest rate of 18.0%; monthly principal and interest payments of $4,422, maturing in 2023. 171,169 176,764 955,074 960,669 Less: Current portion (24,683 ) - $ 930,391 $ 960,669 The notes and other receivables from WGP are classified as long term due to ongoing disputes between the Company and WGP. The Company recently won an arbitration hearing against WGP, but will not |
Note 4 - Notes Payable
Note 4 - Notes Payable | 3 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Debt Disclosure [Text Block] | NOTE 4 December 2017 On December 29, 2017 $800,000 8% December 31, 2018. December 31, 2018, December 31, 2019. may $1.50 The note holders also received warrants which entitle the note holders to purchase up to 533,333 $1.50 October 17, 2022. The placement agent for the offering received a cash commission of $64,000, 106,667 $1.50 December 29, 2022. The Company allocated the proceeds between the note and the warrants based on their relative fair values. The relative fair value of the 640,000 $607,024 $128,976 The $64,000 $48,562 $15,438, During May 2018, $575,000 383,333 $15,233 10,155 All debt discounts are being recognized on a straight-line basis over the terms of the notes. Amortization expense related to the debt discounts were $51,749 $0 three December 31, 2018 2017, February 2018 On February 12, 2018 $810,000 8% December 31, 2018. December 31, 2018, December 31, 2019. may $1.50 The note holders also received warrants which entitle the note holders to purchase up to 540,000 $1.50 October 17, 2022. The Company allocated the proceeds between the note and the warrants based on their relative fair values. The relative fair value of the 540,000 $523,013 $286,987 During July 2018, $375,000 250,000 $14,704 9,802 In October 2018, $45,000 30,000 $1,992 1,328 All debt discounts are being recognized on a straight-line basis over the terms of the notes. Amortization expense related to the debt discounts were $87,001 $0 three December 31, 2018 2017, Related Party On February 1, 2016, $200,000. May 1, 2016, $1,000,000. July 14, 2016, $521,297 $2,431,646. one On July 14, 2016, two Of the amounts owed to SCP, $500,000 400,000 $1.25 The remaining $1,756,646 two The first $1,000,000, 9.5% December 31, 2019. $1.25 not If the average closing price of our common stock is at least $2.50 twenty twenty 100,000 may, 10 twenty 45 The second $756,646, 8% December 31, 2019. not first December 31, 2019. Accrued interest on these notes payable was $219 $12,742 December 31, 2018 September 30, 2018, 800,000 $1.50 800,000 $3.00 June 30, 2020. $72,651 December 31, 2018, $1,756,646, $20,332. $5,341 $5,341 three December 31, 2018 2017. |
Note 5 - Related Party Transact
Note 5 - Related Party Transactions | 3 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Related Party Transactions Disclosure [Text Block] | NOTE 5 Strategic Capital Partners. December 31, 2018 September 30, 2018, $1,776,978 $1,782,319, Interest expense was $33,861 $37,390 three December 31, 2018 2017, $219 $12,742 December 31, 2018 September 30, 2018, $51,726 three December 31, 2018. In October 2018, $30,000 Bask, Inc. April 7, 2016, one Pursuant to the agreements, we agreed to provide BASK with financing for construction and working capital required for BASK’s approved dispensary and cultivation center in Fairhaven, MA. The financing accrued interest of 18% 6 five 18%. On August 15, 2018, 6 first $129,634 $44,517 5 18% $171,169 $176,764 December 31, 2018 September 30, 2018, December 31, 2018, $7,672. For a three April 1, 2016, $10,000 not six not Tim Keogh, our Chief Executive Officer, has been a Board Member of BASK since August 2013. November 7, 2012, .c.180. In October 2017, may Existing RMDs with a Final Certificate of Registration may may not 10% |
Note 6 - Loss Per Share
Note 6 - Loss Per Share | 3 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Earnings Per Share [Text Block] | NOTE 6 The following table sets forth the computation of basic and diluted net loss per share: Three Monthds Ended December 31, 2018 2017 Net loss attributable to common stockholders $ (538,508 ) $ (1,374,364 ) Basic weighted average outstanding shares of common stock 22,568,375 19,366,000 Dilutive effects of common share equivalents - - Dilutive weighted average outstanding shares of common stock 22,568,375 19,366,000 Basic and diluted net loss per share of common stock $ (0.02 ) $ (0.07 ) As of December 31, 2018, 150,000 9,170,650 December 31, 2017, 1,305,000 11,566,000 |
Note 7 - Commitments and Contin
Note 7 - Commitments and Contingencies | 3 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Commitments and Contingencies Disclosure [Text Block] | NOTE 7 Officer Employment Agreement. March 25, 2014, three 50% $12,000 MMCC. January 14, 2015, 52.6 47 may $100,000 Between August 2015 September 2016, October 14, 2016. $4,325,000 $725,000, September 30, 2016, $925,000 October 17, 2016, Operating Leases Land On October 17, 2016, 52.6 $925,000 $4,475,000. $3,550,000 47 As part of a simultaneous transaction, the Company assigned the property rights to MMP for a nominal fee and entered a lease agreement pursuant to which MMP agreed to lease the property to the Company for an initial term of fifty 50 four 4 ten 10 The lease payments will be the greater of (a) $30,000 $0.38 1.5% not five 5 Between October 17, 2016 April 17, 2017, April 17, 2017. April 17, 2017, Under the terms of the lease, the Company had six 6 $2.6 first six 6 six 6 twelve 12 October 17, 2016, October 17, 2017, 16 October 17, 2016 $2.6 100,000 $1.50 October 17, 2017 October 17, 2022. February April, 2018, 20 October 17, 2016 $2.6 100,000 $1.50 October 17, 2022. $0 three December 31, 2018 July 2018, $2.6 The Company received a credit for the $925,000 fifty 50 $1,542 In connection with the sale of the property to MMP and the lease, the Company and MMP entered into a Share Purchase Agreement pursuant to which the Company issued to MMP 100,000 $0.0001 3,640,000 $1.00 October 17, 2018 October 17, 2020. not ● Risk-free interest rate – 1.12 ● Expected term – 4.0 ● Volatility – 115 The Company allocated $1,899,966 $73,000, The lease expense, which includes the amortization related to the prepaid land lease and office space, was $99,865 $108,625 three December 31, 2018 2017. December 31, 2018, $256,122 2019, $341,496 2020 2023, $14,684,528 Office space In January 2018 1550 80202. $1,230 $3,750 three December 31, 2018 $8,760 three December 31, 2017. |
Note 8 - Shareholders' Equity
Note 8 - Shareholders' Equity | 3 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Stockholders' Equity Note Disclosure [Text Block] | NOTE 8 Equity Line Agreement. December 12, 2017, $10,000,000 During the term of the Agreement, the Company, at its sole discretion, may one 10 $500,000. A closing will occur on the date which is no five no seven The amount to be paid by MSC on a particular Closing Date will be determined by dividing the dollar amount specified in the Put Notice by the Purchase Price. The Purchase Price is 90% five no may not The Company may 75% may, not $1.00 The Company is under no The equity line agreement has a term of 18 February 14, 2018. During the three December 31, 2018, 311,816 $650,000 In October 2018, 65,000 Restricted Stock Awards. December 31, 2018, no $0 $0 three December 31, 2018 2017, December 31, 2018, no Stock Options . no December 31, 2018. Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding as of September 30, 2018 150,000 $ 2.21 - $ - Outstanding as of December 31, 2018 150,000 $ 2.50 2.6 $ - Vested and expected to vest at December 31, 2018 150,000 $ 2.50 2.6 $ - Exercisable at December 31, 2018 150,000 $ 2.50 2.6 $ - There was no three December 31, 2018 2017. December 31, 2018, no Warrants. three December 31, 2018 Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding as of September 30, 2018 9,478,650 $ 1.55 2.6 Exercised (308,000 ) 1.28 Outstanding as of December 31, 2018 9,170,650 $ 1.56 2.6 $ 7,120,776 Exercisable at December 31, 2018 5,530,650 $ 1.92 2.6 $ 3,007,576 During the three December 31, 2018, 308,000 $395,500. |
Note 9 - Subsequent Events
Note 9 - Subsequent Events | 3 Months Ended |
Dec. 31, 2018 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | NOTE 9 As part of the existing agreement with MSC, on January 9, 2019, 95,708 $170,000 In February 2019, $30,000 20,000 4. |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 3 Months Ended |
Dec. 31, 2018 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | Basis of Presentation The (a) balance sheet as of September 30, 2018, three December 31, 2018 2017, 10 January 15, 2019. not 2018 10 Certain prior period amounts have been reclassified to conform with current period presentation. These reclassifications have no |
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] | Restricted Cash The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts in the consolidated statements of cash flows: December 31, September 30, 2018 Cash and cash equivalents $ 71,817 $ 198,144 Restricted cash 4,435,085 3,818,805 Total cash, cash equivalents, and restricted cash shown in the cash flow statement $ 4,506,902 $ 4,016,949 Amounts included in restricted cash represent those required to be set aside by a contractual agreement with a lender for the payment of specific construction related expenditures as part of the Company’s property development in Massachusetts. |
New Accounting Pronouncements, Policy [Policy Text Block] | Recent Accounting Pronouncements In January 2018, No. 2018 01, 842 842; February 25, 2016, No. 2016 02, 842 842. 842 2016 02, not may 10 350 30. 1, 2019, 2016 02. 842 not In July 2017, No. 2017 11, 260 480 815 no December 15, 2018, October 1, 2018 not In May 2017, No. 2017 09, 718 1 2 718, 718. December 15, 2017, October 1, 2018 not In February 2017, No. 2017 05, 610 20 610 20, 610 20, May 2014 No. 2014 09, 606 December 15, 2017, No. 2014 09, 1, 2018 not In January 2017, No. 2017 03, 250 No. 2014 09, 606 No. 2016 02, 842 No. 2016 13, 326 No. 2014 09 1, 2018 not Between May 2014 December 2016, 606 five may December 15, 2017, 606, October 1, 2018 not In February 2016, No. 2016 02, 842 2016 02” 2016 02 2016 02, 12 2016 02 December 15, 2018 ( 2016 02 |
Note 1 - Nature of Business a_2
Note 1 - Nature of Business and Basis of Presentation (Tables) | 3 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Cash, Cash Equivalents, and Restricted Cash [Table Text Block] | December 31, September 30, 2018 Cash and cash equivalents $ 71,817 $ 198,144 Restricted cash 4,435,085 3,818,805 Total cash, cash equivalents, and restricted cash shown in the cash flow statement $ 4,506,902 $ 4,016,949 |
Note 3 - Notes and Other Rece_2
Note 3 - Notes and Other Receivables (Tables) | 3 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] | December 31, September 30, 2018 Notes and other receivables from WGP, a licensed medical marijuana cultivator; $673,294 note secured by real and personal property of the borrower, interest rate of 18.0%; accrued consulting and legal fees of $206,675, construction advances of $332,357 and accrued interest of $549,349. Net of reserves of $977,770. All amounts are due and payable immediately. $ 783,905 $ 783,905 Related party note receivable from BASK, a non-profit corporation, interest rate of 18.0%; monthly principal and interest payments of $4,422, maturing in 2023. 171,169 176,764 955,074 960,669 Less: Current portion (24,683 ) - $ 930,391 $ 960,669 |
Note 6 - Loss Per Share (Tables
Note 6 - Loss Per Share (Tables) | 3 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | Three Monthds Ended December 31, 2018 2017 Net loss attributable to common stockholders $ (538,508 ) $ (1,374,364 ) Basic weighted average outstanding shares of common stock 22,568,375 19,366,000 Dilutive effects of common share equivalents - - Dilutive weighted average outstanding shares of common stock 22,568,375 19,366,000 Basic and diluted net loss per share of common stock $ (0.02 ) $ (0.07 ) |
Note 8 - Shareholders' Equity (
Note 8 - Shareholders' Equity (Tables) | 3 Months Ended |
Dec. 31, 2018 | |
Notes Tables | |
Share-based Compensation, Stock Options, Activity [Table Text Block] | Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding as of September 30, 2018 150,000 $ 2.21 - $ - Outstanding as of December 31, 2018 150,000 $ 2.50 2.6 $ - Vested and expected to vest at December 31, 2018 150,000 $ 2.50 2.6 $ - Exercisable at December 31, 2018 150,000 $ 2.50 2.6 $ - |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | Weighted Weighted Average Average Contractual Aggregate Number of Exercise Term Intrinsic Shares Price (Years) Value Outstanding as of September 30, 2018 9,478,650 $ 1.55 2.6 Exercised (308,000 ) 1.28 Outstanding as of December 31, 2018 9,170,650 $ 1.56 2.6 $ 7,120,776 Exercisable at December 31, 2018 5,530,650 $ 1.92 2.6 $ 3,007,576 |
Note 1 - Nature of Business a_3
Note 1 - Nature of Business and Basis of Presentation (Details Textual) | Jan. 17, 2014 |
Ownership Percentage, Transfered | 93.00% |
Note 1 - Nature of Business a_4
Note 1 - Nature of Business and Basis of Presentation - Restricted Cash (Details) - USD ($) | Dec. 31, 2018 | Sep. 30, 2018 | Dec. 31, 2017 | Sep. 30, 2017 |
Cash and cash equivalents | $ 71,817 | $ 198,144 | ||
Restricted cash | 4,435,085 | 3,818,805 | ||
Total cash, cash equivalents, and restricted cash shown in the cash flow statement | $ 4,506,902 | $ 4,016,949 | $ 1,097,835 | $ 1,627 |
Note 2 - Going Concern (Details
Note 2 - Going Concern (Details Textual) - USD ($) | Jan. 18, 2018 | Dec. 31, 2018 | Dec. 31, 2017 | Sep. 30, 2018 |
Retained Earnings (Accumulated Deficit), Ending Balance | $ (13,648,049) | $ (13,109,541) | ||
Net Income (Loss) Attributable to Parent, Total | (538,508) | $ (1,374,364) | ||
Allowance for Notes, Loans and Financing Receivable, Noncurrent | 977,770 | 977,770 | ||
Demand for Arbitration against WGP [Member] | ||||
Litigation Settlement, Amount Awarded from Other Party | $ 1,045,000 | |||
Litigation Settlement, Amount Awarded Receivable from Other Party, Interest Rate | 18.00% | |||
Litigation Settlement Interest | $ (550,000) | |||
Litigation Settlement, Amount Awarded from Other Party, Including Interest | $ 1,595,000 | |||
Wellness Group Pharms LLC [Member] | ||||
Notes, Loans and Financing Receivable, Gross, Noncurrent | 1,761,675 | |||
Allowance for Notes, Loans and Financing Receivable, Noncurrent | $ 977,770 | $ 977,770 |
Note 3 - Notes and Other Rece_3
Note 3 - Notes and Other Receivables - Schedule of Notes Receivable (Details) - USD ($) | Dec. 31, 2018 | Sep. 30, 2018 |
Notes and other receivables | $ 955,074 | $ 960,669 |
Less: Current portion | (24,683) | |
930,391 | 960,669 | |
Wellness Group Pharms LLC [Member] | ||
Notes and other receivables | 783,905 | 783,905 |
BASK [Member] | Maturing in 2023 [Member] | ||
Notes and other receivables | $ 171,169 | $ 176,764 |
Note 3 - Notes and Other Rece_4
Note 3 - Notes and Other Receivables - Schedule of Notes Receivable (Details) (Parentheticals) - USD ($) | 3 Months Ended | 12 Months Ended |
Dec. 31, 2018 | Sep. 30, 2018 | |
Notes and other receivables, allowance | $ 977,770 | $ 977,770 |
Maturing in 2023 [Member] | ||
Interest rate | 18.00% | 18.00% |
Periodic payment | $ 4,422 | |
Wellness Group Pharms LLC [Member] | ||
Secured note | $ 673,294 | $ 673,294 |
Interest rate | 18.00% | 18.00% |
Accrued consulting fees | $ 206,675 | $ 206,675 |
Construction advances | 332,357 | 332,357 |
Accrued interest | 549,349 | 549,349 |
Notes and other receivables, allowance | $ 977,770 | $ 977,770 |
Note 4 - Notes Payable (Details
Note 4 - Notes Payable (Details Textual) | Feb. 12, 2018USD ($)$ / sharesshares | Dec. 29, 2017USD ($)$ / sharesshares | Jul. 14, 2016USD ($)$ / sharesshares | Oct. 31, 2018USD ($)shares | Jul. 31, 2018USD ($)shares | May 31, 2018USD ($)shares | Dec. 31, 2018USD ($)$ / shares | Dec. 31, 2017USD ($) | Sep. 30, 2018USD ($)$ / shares | May 01, 2016USD ($) | Feb. 01, 2016USD ($) |
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.56 | $ 1.55 | |||||||||
Debt Instrument, Unamortized Discount, Total | $ 0 | $ 138,750 | |||||||||
Amortization of Debt Discount (Premium) | 133,409 | $ 708,645 | |||||||||
Strategic Capital Partners [Member] | |||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 1.25 | ||||||||||
Debt Conversion, Converted Instrument, Shares Issued | shares | 400,000 | ||||||||||
Amortization of Debt Discount (Premium) | 5,341 | 5,341 | |||||||||
Line of Credit Outstanding Amount Assumed by Related Party | $ 521,297 | ||||||||||
Notes Payable, Related Parties | 2,431,646 | 1,756,646 | |||||||||
Debt Instrument, Unamortized Premium, Total | 72,651 | 20,332 | |||||||||
Conversion from December 2017 Convertible Notes to Common Stock [Member] | |||||||||||
Debt Conversion, Original Debt, Amount | $ 575,000 | ||||||||||
Debt Conversion, Converted Instrument, Shares Issued | shares | 383,333 | ||||||||||
Debt Conversion, Accrued Interest | $ 15,233 | ||||||||||
Debt Conversion, Converted Interest payable, Shares Issued | shares | 10,155 | ||||||||||
February 2018 Convertible Notes, Loan Principal Converted into Common Stock [Member] | |||||||||||
Debt Conversion, Converted Instrument, Shares Issued | shares | 30,000 | 250,000 | |||||||||
February 2018 Convertible Notes, Interest Payable Converted into Common Stock [Member] | |||||||||||
Debt Conversion, Original Debt, Amount | $ 1,992 | $ 14,704 | |||||||||
Debt Conversion, Converted Instrument, Shares Issued | shares | 1,328 | 9,802 | |||||||||
Debt Converted into Common Stock [Member] | Strategic Capital Partners [Member] | |||||||||||
Debt Conversion, Original Debt, Amount | 500,000 | ||||||||||
Debt Converted into Promissory Notes [Member] | Strategic Capital Partners [Member] | |||||||||||
Debt Conversion, Original Debt, Amount | $ 1,756,646 | ||||||||||
December 2017 Convertible Notes [Member] | GVC Capital LLC [Member] | |||||||||||
Payments of Debt Issuance Costs | $ 64,000 | ||||||||||
Debt Instrument, Unamortized Discount, Total | 15,438 | ||||||||||
Adjustments to Additional Paid in Capital, Warrant Issued | $ 48,562 | ||||||||||
Promissory Note One [Member] | Strategic Capital Partners [Member] | |||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 9.50% | ||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 1.25 | ||||||||||
Notes Payable, Related Parties | $ 1,000,000 | ||||||||||
Average Closing Price per Share | $ / shares | $ 2.50 | ||||||||||
Convertible Debt, Number of Trading Days | 20 | ||||||||||
Average Daily Volume Of Shares Trades | shares | 100,000 | ||||||||||
Period to Notify End of Right to Convert Notes | 10 days | ||||||||||
Period before Right to Convert Notes Expires | 45 days | ||||||||||
Promissory Note Two [Member] | Strategic Capital Partners [Member] | |||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | ||||||||||
Notes Payable, Related Parties | $ 756,646 | ||||||||||
Interest Payable | 219 | $ 12,742 | |||||||||
Warrants Issued to Accredited Investors [Member] | December 2017 Convertible Notes [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 533,333 | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.50 | ||||||||||
Warrants Issued to Accredited Investors [Member] | February 2018 Convertible Notes [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 540,000 | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.50 | ||||||||||
Warrants Issued to Placement Agent [Member] | December 2017 Convertible Notes [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 106,667 | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.50 | ||||||||||
Warrants Issued to Accredited Investors and Placement Agent [Member] | December 2017 Convertible Notes [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 640,000 | ||||||||||
February 2018 Convertible Notes, Loan Principal Converted into Common Stock [Member] | |||||||||||
Debt Conversion, Original Debt, Amount | $ 45,000 | $ 375,000 | |||||||||
Warrant to Related Party, Set 1 [Member] | Strategic Capital Partners [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 800,000 | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.50 | ||||||||||
Warrants to Purchase Additional Shares [Member] | Strategic Capital Partners [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 800,000 | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 3 | ||||||||||
Unrelated Party [Member] | |||||||||||
Line of Credit Facility, Current Borrowing Capacity | $ 1,000,000 | $ 200,000 | |||||||||
Unrelated Party [Member] | Construction Loans [Member] | |||||||||||
Proceeds from Issuance of Long-term Debt, Total | $ 800,000 | ||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | ||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 1.50 | ||||||||||
Accredited Investors [Member] | Convertible Debt [Member] | December 2017 Convertible Notes [Member] | |||||||||||
Debt Instrument, Unamortized Discount, Total | $ 607,024 | ||||||||||
Debt Instrument, Convertible, Beneficial Conversion Feature | $ 128,976 | ||||||||||
Amortization of Debt Discount (Premium) | 51,749 | 0 | |||||||||
Accredited Investors [Member] | Convertible Debt [Member] | February 2018 Convertible Notes [Member] | |||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 8.00% | ||||||||||
Debt Instrument, Convertible, Conversion Price | $ / shares | $ 1.50 | ||||||||||
Debt Instrument, Unamortized Discount, Total | $ 523,013 | ||||||||||
Debt Instrument, Convertible, Beneficial Conversion Feature | 286,987 | ||||||||||
Amortization of Debt Discount (Premium) | $ 87,001 | $ 0 | |||||||||
Debt Instrument, Face Amount | $ 810,000 |
Note 5 - Related Party Transa_2
Note 5 - Related Party Transactions (Details Textual) - USD ($) | Aug. 15, 2018 | Oct. 31, 2018 | Dec. 31, 2018 | Dec. 31, 2017 | Sep. 30, 2018 | Jul. 14, 2016 |
Interest Expense, Related Party | $ 33,861 | $ 37,390 | ||||
Interest Payable, Current | 44,491 | $ 46,605 | ||||
Interest Paid, Excluding Capitalized Interest, Operating Activities | 51,959 | 54,040 | ||||
Increase (Decrease) in Accrued Interest Receivable, Net | 8,077 | |||||
Strategic Capital Partners [Member] | ||||||
Notes Payable, Related Parties | 1,756,646 | $ 2,431,646 | ||||
Interest Expense, Related Party | 33,861 | $ 37,390 | ||||
Interest Payable, Current | 219 | 12,742 | ||||
Interest Paid, Excluding Capitalized Interest, Operating Activities | 51,726 | |||||
Strategic Capital Partners [Member] | Reimbursements for Travel Expenses [Member] | ||||||
Related Party Transaction, Amounts of Transaction | $ 30,000 | |||||
Strategic Capital Partners [Member] | Notes Payable Converted to Promissory Notes [Member] | ||||||
Notes Payable, Related Parties | 1,776,978 | 1,782,319 | ||||
BASK [Member] | ||||||
Note Receivable, Term | 5 years | |||||
Note Receivable, Interest Rate | 18.00% | |||||
Notes Receivable, Related Parties | $ 129,634 | 171,169 | $ 176,764 | |||
Interest Receivable | $ 44,517 | |||||
Increase (Decrease) in Accrued Interest Receivable, Net | $ 7,672 | |||||
BASK [Member] | Consulting Services [Member] | ||||||
Consulting Services Term | 3 years | |||||
Revenue from Contract with Customer, Monthly | $ 10,000 | |||||
BASK [Member] | Construction Loans [Member] | ||||||
Note Receivable, Term | 5 years | |||||
Note Receivable, Interest Rate | 18.00% | |||||
Chief Executive Officer [Member] | BASK [Member] | ||||||
Ownership Percentage | 10.00% |
Note 6 - Loss Per Share (Detail
Note 6 - Loss Per Share (Details Textual) - shares | 3 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Employee Stock Option [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 150,000 | 1,305,000 |
Warrant [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 9,170,650 | 11,566,000 |
Note 6 - Loss Per Share - Sched
Note 6 - Loss Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) | 3 Months Ended | |
Dec. 31, 2018 | Dec. 31, 2017 | |
Net Income (Loss) Attributable to Parent, Total | $ (538,508) | $ (1,374,364) |
Basic weighted average outstanding shares of common stock (in shares) | 22,568,375 | 19,366,000 |
Dilutive effects of common share equivalents (in shares) | 0 | 0 |
Dilutive weighted average outstanding shares of common stock (in shares) | 22,568,375 | 19,366,000 |
Basic and diluted loss per common share (in dollars per share) | $ (0.02) | $ (0.07) |
Note 7 - Commitments and Cont_2
Note 7 - Commitments and Contingencies (Details Textual) | Apr. 17, 2018USD ($)$ / sharesshares | Oct. 17, 2017USD ($)$ / sharesshares | Oct. 17, 2016USD ($)ayr$ / shares$ / itemshares | Mar. 25, 2014USD ($) | Dec. 31, 2018USD ($)$ / shares | Dec. 31, 2017USD ($) | Sep. 30, 2016USD ($) | Sep. 30, 2016USD ($) | Sep. 30, 2018$ / shares | Dec. 12, 2017$ / shares | Jan. 14, 2015USD ($)a |
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.56 | $ 1.55 | |||||||||
Common Stock, Par or Stated Value Per Share | $ / shares | $ 0.0001 | $ 0.0001 | |||||||||
Operating Leases, Office Space [Member] | |||||||||||
Operating Leases, Rent Expense, Net, Total | $ 3,750 | $ 8,760 | |||||||||
Operating Leases, Monthly Payment | 1,230 | ||||||||||
Additional Paid-in Capital [Member] | |||||||||||
Warrants Issued During Period, Value, Sale Leaseback Transaction | $ 1,899,966 | ||||||||||
Stock Issued During Period, Value, Sale Leaseback Transaction | 73,000 | ||||||||||
Warrants Issued for Lease Amendment #1 [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 100,000 | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.50 | ||||||||||
Warrants Issued for Lease Amendment #3 [Member] | |||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 100,000 | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1.50 | ||||||||||
Allocated Warrants or Rights Expense | 0 | ||||||||||
Sale Leaseback to MMP [Member] | |||||||||||
Payments to Acquire Land | $ 925,000 | ||||||||||
Lessee, Operating Lease, Term of Contract | 50 years | ||||||||||
Lessee Leasing Arrangements, Operating Leases, Number of Renewal Periods | 4 | ||||||||||
Lessee, Operating Lease, Renewal Term | 10 years | ||||||||||
Sale Leaseback Transaction, Monthly Rental Payments | $ 30,000 | ||||||||||
Sale Leaseback Transaction, Monthly Rental Payments, Per Square Foot | $ / item | 0.38 | ||||||||||
Sale Leaseback Transaction, Monthly Rental Payments, Percentage of Gross Monthly Sales | 1.50% | ||||||||||
Sale Leaseback Transaction, Monthly Rental Payments, Adjustment Period | 5 years | ||||||||||
Sale Leaseback Transaction, Period Available to Obtain Capital Funding for Construction of the First Phase Building | 1 year 240 days | 1 year 120 days | 180 days | ||||||||
Sales Leaseback Transaction, Amount of Capital Funding to Obtain For Construction of the First Phase Building | $ 2,600,000 | $ 2,600,000 | $ 2,600,000 | ||||||||
Sale Leaseback Transaction, Additional Period Available to Obtain Capital Funding for Construction of the First Phase Building | 180 days | ||||||||||
Sale Leaseback Transaction, Period Unable to Obtain Capital Funding for Construction of the First Phase Building, After Which the Arrangement Will Terminate | 1 year | ||||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 3,640,000 | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares | $ 1 | $ 1 | |||||||||
Sale Leaseback Transaction, Discount to the Purchase Price, Monthly Reduction in Payments | $ 1,542 | ||||||||||
Stock Issued During Period, Shares, Sale Leaseback Transaction | shares | 100,000 | ||||||||||
Common Stock, Par or Stated Value Per Share | $ / shares | $ 0.0001 | ||||||||||
Sale Leaseback to MMP [Member] | Measurement Input, Risk Free Interest Rate [Member] | |||||||||||
Warrants and Rights Outstanding, Measurement Input | 0.0112 | ||||||||||
Sale Leaseback to MMP [Member] | Measurement Input, Expected Term [Member] | |||||||||||
Warrants and Rights Outstanding, Measurement Input | yr | 4 | ||||||||||
Sale Leaseback to MMP [Member] | Measurement Input, Price Volatility [Member] | |||||||||||
Warrants and Rights Outstanding, Measurement Input | 1.15 | ||||||||||
Massachusetts Land Purchase [Member] | |||||||||||
Area of Land | a | 52.6 | 52.6 | |||||||||
Deposits on Land | $ 100,000 | ||||||||||
Land, Selling Price | $ 4,475,000 | $ 4,325,000 | |||||||||
Payments to Acquire Land | $ 725,000 | $ 925,000 | |||||||||
Payments to Acquire Land Held-for-use | $ 3,550,000 | ||||||||||
Operating Leases, Rent Expense, Net, Total | 99,865 | $ 108,625 | |||||||||
Operating Leases, Future Minimum Payments Due, Next Twelve Months | 256,122 | ||||||||||
Operating Leases, Future Minimum Payments, Due Thereafter | 14,684,528 | ||||||||||
Operating Leases, Future Minimum Payments, Due in Four Years | 341,496 | ||||||||||
Operating Leases, Future Minimum Payments, Due in Three Years | 341,496 | ||||||||||
Operating Leases, Future Minimum Payments, Due in Five Years | 341,496 | ||||||||||
Operating Leases, Future Minimum Payments, Due in Two Years | $ 341,496 | ||||||||||
Chief Executive Officer [Member] | |||||||||||
Officer Employment Agreement, Initial Term | 3 years | ||||||||||
Chief Executive Officer [Member] | Officer Employment Agreement [Member] | |||||||||||
Officer Employment Agreement, Time Devoted, Percentage | 50.00% | ||||||||||
Officer Employment Agreement, Monthly Payment | $ 12,000 |
Note 8 - Shareholders' Equity_2
Note 8 - Shareholders' Equity (Details Textual) - USD ($) | Dec. 12, 2017 | Oct. 31, 2018 | Dec. 31, 2018 | Dec. 31, 2017 | Sep. 30, 2018 | Oct. 17, 2016 |
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 1.56 | $ 1.55 | ||||
Proceeds from Issuance of Common Stock | $ 650,000 | |||||
Stock Issued During Period, Shares, Issued for Services | 65,000 | |||||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options | $ 0 | |||||
Stock Issued During Period, Shares, Warrants Exercised | 308,000 | |||||
Stock Issued During Period, Value, Warrants Exercised | $ 395,500 | |||||
Restricted Stock [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance | 0 | |||||
Allocated Share-based Compensation Expense, Total | $ 0 | 0 | ||||
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options | 0 | |||||
Employee Stock Option [Member] | ||||||
Allocated Share-based Compensation Expense, Total | 0 | $ 0 | ||||
Sale Leaseback to MMP [Member] | ||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ 1 | $ 1 | ||||
Equity Line Agreement [Member] | ||||||
Purchase Price of Weighted Average Price of Common Stock | 90.00% | |||||
Percentage of Closing Price of Common Stock | 75.00% | |||||
Stock Issued During Period, Value, New Issues | 311,816 | |||||
Proceeds from Issuance of Common Stock | $ 650,000 | |||||
Mountain States Capital, LLC [Member] | ||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 10,000,000 | |||||
Line of Credit Facility, Current Borrowing Capacity | $ 500,000 | |||||
Debt Instrument, Term | 1 year 180 days |
Note 8 - Shareholders' Equity -
Note 8 - Shareholders' Equity - Stock Option Activity (Details) - $ / shares | 3 Months Ended | 12 Months Ended |
Dec. 31, 2018 | Sep. 30, 2018 | |
Shares Outstanding (in shares) | 150,000 | 150,000 |
Outstanding, weighted average exercise price (in dollars per share) | $ 2.50 | $ 2.21 |
Outstanding, weighted average contractual term (Year) | 2 years 219 days | |
Shares Vested and expected to vest (in shares) | 150,000 | |
Vested and expected to vest, weighted average exercise price (in dollars per share) | $ 2.50 | |
Vested and expected to vest, weighted average contractual term (Year) | 2 years 219 days | |
Shares Exercisable (in shares) | 150,000 | |
Exercisable, weighted average exercise price (in dollars per share) | $ 2.50 | |
Exercisable, weighted average contractual term (Year) | 2 years 219 days |
Note 8 - Shareholders' Equity_3
Note 8 - Shareholders' Equity - Warrant Activity (Details) - USD ($) | 3 Months Ended | 12 Months Ended |
Dec. 31, 2018 | Sep. 30, 2018 | |
Outstanding, warrants (in shares) | 9,478,650 | |
Outstanding, warrants, weighted average exercise price (in dollars per share) | $ 1.55 | |
Outstanding, warrants, weighted average remaining contract term (Year) | 2 years 219 days | 2 years 219 days |
Exercised, warrants (in shares) | (308,000) | |
Exercised, warrants, weighted average exercise price (in dollars per share) | $ 1.28 | |
Outstanding, warrants (in shares) | 9,170,650 | 9,478,650 |
Outstanding, warrants, weighted average exercise price (in dollars per share) | $ 1.56 | $ 1.55 |
Class of warrant or right, outstanding, aggregate intrinsic value | $ 7,120,776 | |
Exercisable, warrants (in shares) | 5,530,650 | |
Exercisable, warrants, weighted average exercise price (in dollars per share) | $ 1.92 | |
Exercisable, warrants, weighted average remaining contract term (Year) | 2 years 219 days | |
Class of warrant or right, exercisable, aggregate intrinsic value | $ 3,007,576 |
Note 9 - Subsequent Events (Det
Note 9 - Subsequent Events (Details Textual) - USD ($) | Jan. 09, 2019 | Feb. 28, 2019 | Dec. 31, 2018 | Dec. 31, 2017 |
Proceeds from Issuance of Common Stock | $ 650,000 | |||
Subsequent Event [Member] | ||||
Debt Conversion, Original Debt, Amount | $ 30,000 | |||
Debt Conversion, Converted Instrument, Shares Issued | 20,000 | |||
Equity Line Agreement [Member] | ||||
Stock Issued During Period, Value, New Issues | 311,816 | |||
Proceeds from Issuance of Common Stock | $ 650,000 | |||
Equity Line Agreement [Member] | Subsequent Event [Member] | ||||
Stock Issued During Period, Value, New Issues | $ 95,708 | |||
Proceeds from Issuance of Common Stock | $ 170,000 |